References
- CohenDBogersJPvan DijkDBakkerBSchultePFBeyond white blood cell monitoring: screening in the initial phase of clozapine therapyJ Clin Psychiatry201273101307131223140648
- GaertnerHJFischerEHossJSide effects of clozapinePsychopharmacology (Berl)198999SupplS97S1002813671
- HummerMKurzMKurzthalerIOberbauerHMillerCFleischhackerWWHepatotoxicity of clozapineJ Clin Psychopharmacol19971743143179241012
- US National Library of MedicineLiverTox database Available from: http://livertox.nih.gov/Naranjoassessment.pdfAccessed August 5, 2014
- LeeWMDrug-induced hepatotoxicityN Engl J Med2003349547448512890847
- MacfarlaneBDaviesSMannanKSarsamRParienteDDooleyJFatal acute fulminant liver failure due to clozapine: a case report and review of clozapine-induced hepatotoxicityGastroenterology19971125170717099136851
- KellnerMWiedemannKKriegJCBergPAToxic hepatitis by clozapine treatmentAm J Psychiatry19931509859868494085
- ErdoganAKocabasogluNYalugIOzbayGSenturkHManagement of marked liver enzyme increase during clozapine treatment: a case report and review of the literatureInt J Psychiatry Med2004341838915242144
- ThatcherGWCatesMBairBClozapine-induced toxic hepatitisAm J Psychiatry199515222962977840371
- LuoDMcCollPWalmsleyRAcute onset of ascites with clozapine-induced hepatitisIntern Med J200737320420517316346
- BrownCATelioSWarnockCAWongAHClozapine toxicity and hepatitisJ Clin Psychopharmacol201333457057123764687
- KeaneSLaneALarkinTClarkeMManagement of clozapine-related hepatotoxicityJ Clin Psychopharmacol200929660660719910731
- ChangAKrygierDSChaturNYoshidaEMClozapine-induced fatal fulminant hepatic failure: a case reportCan J Gastroenterol200923537637819440569
- ThompsonJChengappaKNGoodCBHepatitis, hyperglycemia, pleural effusion, eosinophilia, hematuria and proteinuria occurring early in clozapine treatmentInt Clin Psychopharmacol199813295989669191
- WorrallRWilsonACullenMDystonia and drug-induced hepatitis in a patient treated with clozapineAm J Psychiatry199515246476487694924
- KangSHLeeJEosinophilia, pleural effusion, hepatitis, and jaundice occurring early in clozapine treatmentClin Psychopharmacol Neurosci201311210310524023555
- GaertnerIAltendorfKBatraAGaertnerHJRelevance of liver enzyme elevations with four different neuroleptics: a retrospective review of 7,263 treatment coursesJ Clin Psychopharmacol200121221522211270919
- MarinkovicDTimotijevicIBabinskiTToticSPaunovicVRThe side-effects of clozapine: a four year follow-up studyProg Neuropsychopharmacol Biol Psychiatry19941835375448078987
- SubramaniamMNgCChongSAMetabolic differences between Asian and Caucasian patients on clozapine treatmentHum Psychopharmacol200722421722217431927
- OzdemirVKalowWPosnerPCYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentration in patients with schizophreniaJ Clin Psychopharmacol200121439840711476124
- NielsenJCorrellCUManuPKaneJMTermination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?J Clin Psychiatry2013746603613 quiz 61323842012
- FreudenreichOGandhiRTWalshJPHendersonDCGoffDCHepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohortPsychosomatics200748540541117878499
- TaylorDPatonCShitijKThe Maudsley Prescribing Guidelines10th edLondonInforma Healthcare2011
- MarkowitzJSGrinbergRJacksonCMarked liver enzyme elevations with clozapineJ Clin Psychopharmacol199717170719004073